Protein Engineering Company
Cart 0
RAF1-RBD, biotinylated | Inhibitor screening for RAS/RAF interaction | Cancer Drug Discovery

Amid Biosciences | Protein Engineering Company

Raf1 RBD Protein, Human, Recombinant, Biotinylated

$ 800.00

Ras Binding Domain (RBD) of Human Raf-1 Proto-Oncogene, Serine/Threonine Kinase (RAF1), (UniProt # P04049, amino acids 50-140) with the N-terminal AviTag™ peptide and His-tag is produced in E. coli cells and site-specifically biotinylated at AviTag with BirA enzyme (

The Raf1 RBD protein binds specifically to GTP-bound Ras proteins. Ras proteins, like other small GTPases, regulate molecular events by cycling between an inactive GDP-bound form and an active GTP-bound form. In its active (GTP-bound) state, Ras binds specifically to the Ras-binding domain (RBD) of Raf1 to control downstream signaling cascades. The affinity between RBD and GDP-bound Ras is three orders of magnitude lower (1). Therefore, the RBD protein can be used to specifically precipitate active, GTP-bound Ras as well as to specifically block the activity of Ras in vitro and in vivo.


  • Measurement of the GTP/GDP bound ratio of Ras in vitro.
  • Quantitation of GTP-bound Ras from tissue and tissue culture cell lysates.
  • RAS/RAF binding studies.
  • Inhibitor screening for RAS/RAF interaction

MW: ~13.4 kDa
Tag(s): The N-terminal 6XHis and AviTag™
Amino Acids: 50-140 of Raf1, UniProt # P04049

Catalog # RAF1-B-301

Storage buffer: 20 mM HEPES, pH 7.5, 150 mM NaCl, 5 mM 2-mercaptoethanol, 1 mM MgCl2, and 10% glycerol
Purity: >90% by Coomassie staining 
Storage is recommended at -80°C for longer periods of time. 

International Shipping:  Product requires shipping on ice packs. Please contact for shipment estimates

This product is for laboratory research use only.

For Bulk Orders or Custom Packaging, please contact:

de Rooij, J., Bos, J. Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. Oncogene 14623–625 (1997).

Share this Product

More from this collection